SNOA
Sonoma Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
7.13 / 10
Outperform
Fund flow analysis shows a good score of 7.13/10, but all flow trends (overall, block, small, medium, large, extra-large) are negative, indicating outflow despite the high score. There is no analyst coverage data available. The combination of negative fund trends and lack of analyst support adds to the cautious view, aligning with the overall neutral sentiment.
Fund Flow Rating
What is the analyst consensus for SNOA?
- SNOA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.13/10 (Outperform).
